Progress and Challenges in the Diagnosis of Dementia: A Critical Review
The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Abstract
Longer life expectancies have led to an increased number of neurodegenerative disease cases globally. Accurate diagnosis of this devastating disorder is of crucial importance but is still feasible only by a brain biopsy after death. An enormous amount of attention and research has been in place over the years toward the better understanding of the mechanisms, as well as the early diagnosis, of neurodegeneration. However, numerous studies have been contradictory from time to time, while new diagnostic methods are constantly developed in a tireless effort to tackle the disease. Nonetheless, there is not yet a conclusive report covering a broader range of techniques for the diagnosis of different types of dementia. In this paper, we critically review current knowledge on the different hypotheses about the pathogenesis of distinct types of dementia, as well as risk factors and current diagnostic approaches in a clinical setting, including neuroimaging, cerebrospinal (CSF), and blood tests. Encouraging research results for the diagnosis and investigation of neurodegenerative disorders are also reported. Particular attention is given to the field of spectroscopy as an emerging tool to detect dementias, follow-up patients, and potentially monitor the patients' response to a therapeutic approach. Spectroscopic techniques, such as infrared and Raman spectroscopy, have facilitated numerous disease-related studies, including neurodegenerative disorders, and are currently undergoing trials for clinical implementation. This review constitutes a comprehensive report with an in-depth focus on promising imaging, molecular biomarker and spectroscopic tests in the field of dementive diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295
(2015) · HAL · Cited by 2,238
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
The clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,825
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Alzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., O’Neil, J. P., Janabi, M., Lazaris, A., Cantwell, A., et al. (2016) · Brain · doi:10.1093/brain/aww027 · Cited by 1,185
Bang, J., Spina, S., & Miller, B. L. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00461-4 · Cited by 1,144
O'Brien, J. T., & Thomas, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00463-8 · Cited by 1,136
Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football
Mez, J., Daneshvar, D. H., Kiernan, P. T., Abdolmohammadi, B., Alvarez, V. E., Huber, B. R., Alosco, M. L., Solomon, T. M., Nowinski, C. J., McHale, L., et al. (2017) · JAMA · doi:10.1001/jama.2017.8334 · Cited by 1,098
Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease
Mattsson, N., Andreasson, U., Zetterberg, H., Blennow, K., & Initiative, F. T. A. D. N. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.6117 · Cited by 1,070
Epidemiology of Alzheimer Disease
Mayeux, R., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,064
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence
Hamer, M., & Chida, Y. (2009) · Psychological Medicine · doi:10.1017/s0033291708003681 · Cited by 988
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933
the TBI/CTE group, McKee, A. C., Cairns, N. J., Dickson, D. W., Folkerth, R. D., Dirk Keene, C., Litvan, I., Perl, D. P., Stein, T. D., Vonsattel, J.-P., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1515-z · Cited by 885
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863
McKeith, I. G. (2004) · Dialogues in Clinical Neuroscience · doi:10.1383/psyt.4.1.52.58314 · Cited by 802
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00124 · Cited by 707
Barker, W. W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 705
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
Motter, R., Vigo‐Pelfrey, C., Kholodenko, D., Barbour, R., Johnson‐Wood, K., Galasko, D., Chang, L., Miller, B., Clark, C., Green, R., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380413 · Cited by 701
Dementia associated with Parkinson's disease
Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 685
Andreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.673 · Cited by 660
Detecting Dementia With the Mini-Mental State Examination in Highly Educated Individuals
O’Bryant, S. E., Humphreys, J. D., Smith, G. E., Ivnik, R. J., Graff-Radford, N. R., Petersen, R. C., & Lucas, J. A. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.963 · Cited by 654
Lang, L., Clifford, A., Wei, L., Zhang, D., Leung, D., Augustine, G., Danat, I. M., Zhou, W., Copeland, J. R., Anstey, K. J., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-011146 · Cited by 642
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30159-x · Cited by 626
Walker, Z., Possin, K. L., Boeve, B. F., & Aarsland, D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00462-6 · Cited by 592
Relationship Between Education and Dementia: An Updated Systematic Review
Sharp, E. S., & Gatz, M. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318211c83c · Cited by 591
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Compta, Y., Parkkinen, L., O'Sullivan, S. S., Vandrovcova, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 583
Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582
Vann Jones, S. A., & O'Brien, J. T. (2014) · Psychological Medicine · doi:10.1017/s0033291713000494 · Cited by 546
Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders
Novarino, G., Fenstermaker, A. G., Zaki, M. S., Hofree, M., Silhavy, J. L., Heiberg, A. D., Abdellateef, M., Rosti, B., Scott, E., Mansour, L., et al. (2014) · Science · doi:10.1126/science.1247363 · Cited by 536
Neurodegenerative Diseases: An Overview of Environmental Risk Factors
Brown, R. C., Lockwood, A. H., & Sonawane, B. R. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7567 · Cited by 512
Identifying and validating biomarkers for Alzheimer's disease
Humpel, C. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.09.007 · Cited by 484
The role of tau in neurodegeneration
Gendron, T. F., & Petrucelli, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-13 · Cited by 478
Proteome-based plasma biomarkers for Alzheimer's disease
Hye, A., Lynham, S., Thambisetty, M., Causevic, M., Campbell, J., Byers, H. L., Hooper, C., Rijsdijk, F., Tabrizi, S. J., Banner, S., et al. (2006) · Brain · doi:10.1093/brain/awl279 · Cited by 464
Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study
van Oijen, M., Hofman, A., Soares, H. D., Koudstaal, P. J., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70501-4 · Cited by 458
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Blennow, K., Dubois, B., Fagan, A. M., Lewczuk, P., de Leon, M. J., & Hampel, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.004 · Cited by 455
Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series
Lim, A., Tsuang, D., Kukull, W., Nochlin, D., Leverenz, J., McCormick, W., Bowen, J., Teri, L., Thompson, J., Peskind, E. R., et al. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb02571.x · Cited by 451
Viña, J., & Lloret, A. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100501 · Cited by 447
Graff-Radford, N. R., Crook, J. E., Lucas, J., Boeve, B. F., Knopman, D. S., Ivnik, R. J., Smith, G. E., Younkin, L. H., Petersen, R. C., & Younkin, S. G. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.354 · Cited by 441
Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
Roher, A. E., Esh, C. L., Kokjohn, T. A., Castaño, E. M., Van Vickle, G. D., Kalback, W. M., Patton, R. L., Luehrs, D. C., Daugs, I. D., Kuo, Y., et al. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.10.004 · Cited by 414
Mixed Dementia: Emerging Concepts and Therapeutic Implications
Langa, K. M., Foster, N. L., & Larson, E. B. (2004) · JAMA · doi:10.1001/jama.292.23.2901 · Cited by 398
Plasma tau levels in Alzheimer's disease
Zetterberg, H., Wilson, D., Andreasson, U., Minthon, L., Blennow, K., Randall, J., & Hansson, O. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt163 · Cited by 387
Thal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384
Reassessing the amyloid cascade hypothesis of Alzheimer's disease
Pimplikar, S. W. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.015 · Cited by 375
Risk Factors for Vascular Dementia and Alzheimer Disease
Gorelick, P. B. (2004) · Stroke · doi:10.1161/01.str.0000143318.70292.47 · Cited by 365
Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0825-z · Cited by 359
Sex differences in Alzheimer's disease and other dementias
Mazure, C. M., & Swendsen, J. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00067-3 · Cited by 350
A systematic review of prevalence and incidence studies of dementia with Lewy bodies
Zaccai, J., McCracken, C., & Brayne, C. (2005) · Age and Ageing · doi:10.1093/ageing/afi190 · Cited by 340
Kanai, M., Matsubara, E., Isoe, K., Urakami, K., Nakashima, K., Arai, H., Sasaki, H., Abe, K., Iwatsubo, T., Kosaka, T., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440108 · Cited by 340
Epidemiology of early-onset dementia: a review of the literature
Vieira, R. T., Caixeta, L., Machado, S., Silva, A. C., Nardi, A. E., Arias-Carrión, O., & Carta, M. G. (2013) · Clinical Practice & Epidemiology in Mental Health · doi:10.2174/1745017901309010088 · Cited by 325
Incidence of Dementia With Lewy Bodies and Parkinson Disease Dementia
Savica, R., Grossardt, B. R., Bower, J. H., Boeve, B. F., Ahlskog, J. E., & Rocca, W. A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3579 · Cited by 320
Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
Vanderstichele, H., Kerschaver, E. V., Hesse, C., Davidsson, P., Buyse, M.-A., Andreasen, N., Minthon, L., Wallin, A., Blennow, K., & Vanmechelen, E. (2000) · Amyloid · doi:10.3109/13506120009146438 · Cited by 301
Warren, J. D., Rohrer, J. D., & Rossor, M. N. (2013) · BMJ · doi:10.1136/bmj.f4827 · Cited by 292
Raman Spectroscopy of Blood and Blood Components
Atkins, C. G., Buckley, K., Blades, M. W., & Turner, R. F. B. (2017) · Applied Spectroscopy · doi:10.1177/0003702816686593 · Cited by 292
Cuyvers, E., & Sleegers, K. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00127-7 · Cited by 284
Tau PET imaging: present and future directions
Saint-Aubert, L., Lemoine, L., Chiotis, K., Leuzy, A., Rodriguez-Vieitez, E., & Nordberg, A. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0162-3 · Cited by 282
Neuropathological evaluation of mixed dementia
Jellinger, K. A., & Attems, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.045 · Cited by 272
Nutrition, Brain Aging, and Neurodegeneration: Table 1.
Joseph, J., Cole, G., Head, E., & Ingram, D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3520-09.2009 · Cited by 264
1 H MR spectroscopy in common dementias
Kantarci, K., Petersen, R. C., Boeve, B. F., Knopman, D. S., Tang-Wai, D. F., O’Brien, P. C., Weigand, S. D., Edland, S. D., Smith, G. E., Ivnik, R. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000141849.21256.ac · Cited by 262
Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels
Fukumoto, H., Tennis, M., Locascio, J. J., Hyman, B. T., Growdon, J. H., & Irizarry, M. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.958 · Cited by 257
Tatebe, H., Kasai, T., Ohmichi, T., Kishi, Y., Kakeya, T., Waragai, M., Kondo, M., Allsop, D., & Tokuda, T. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0206-8 · Cited by 256
Stacy, M., Bowron, A., Guttman, M., Hauser, R., Hughes, K., Larsen, J. P., LeWitt, P., Oertel, W., Quinn, N., Sethi, K., et al. (2005) · Movement Disorders · doi:10.1002/mds.20383 · Cited by 246
Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease
Williams, M. M., Xiong, C., Morris, J. C., & Galvin, J. E. (2006) · Neurology · doi:10.1212/01.wnl.0000247041.63081.98 · Cited by 239
Heart disease as a risk factor for dementia
Hakim, A., Ng, & Turek (2013) · Clinical Epidemiology · doi:10.2147/clep.s30621 · Cited by 229
Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease
Schupf, N., Tang, M. X., Fukuyama, H., Manly, J., Andrews, H., Mehta, P., Ravetch, J., & Mayeux, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805902105 · Cited by 225
Choo, L. P., Wetzel, D. L., Halliday, W. C., Jackson, M., LeVine, S. M., & Mantsch, H. H. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79411-0 · Cited by 219
Mild traumatic brain injury: a risk factor for neurodegeneration
Gavett, B. E., Stern, R. A., Cantu, R. C., Nowinski, C. J., & McKee, A. C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt42 · Cited by 216
CSF biomarkers in frontotemporal lobar degeneration with known pathology
Bian, H., Van Swieten, J. C., Leight, S., Massimo, L., Wood, E., Forman, M., Moore, P., de Koning, I., Clark, C. M., Rosso, S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000311445.21321.fc · Cited by 216
Alzheimer disease and Down syndrome: factors in pathogenesis
Lott, I. T., & Head, E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.005 · Cited by 212
Raman Spectroscopy: An Emerging Tool in Neurodegenerative Disease Research and Diagnosis
Devitt, G., Howard, K., Mudher, A., & Mahajan, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00413 · Cited by 212
Plasma Aβ in Alzheimer's disease—up or down?
Zetterberg, H., & Blennow, K. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70503-8 · Cited by 200
Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease
González-Domínguez, R., García-Barrera, T., & Gómez-Ariza, J. L. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.10.010 · Cited by 200
Plasma proteins predict conversion to dementia from prodromal disease
Hye, A., Riddoch‐Contreras, J., Baird, A. L., Ashton, N. J., Bazenet, C., Leung, R., Westman, E., Simmons, A., Dobson, R., Sattlecker, M., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1749 · Cited by 198
Detection of Misfolded Aβ Oligomers for Sensitive Biochemical Diagnosis of Alzheimer’s Disease
Salvadores, N., Shahnawaz, M., Scarpini, E., Tagliavini, F., & Soto, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.031 · Cited by 197
Down syndrome, Alzheimer’s disease and seizures
Menéndez, M. (2005) · Brain and Development · doi:10.1016/j.braindev.2004.07.008 · Cited by 186
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
Brys, M., Pirraglia, E., Rich, K., Rolstad, S., Mosconi, L., Switalski, R., Glodzik-Sobanska, L., De Santi, S., Zinkowski, R., Mehta, P., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.010 · Cited by 185
Cedazo-Mínguez, Á., & Winblad, B. G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.09.008 · Cited by 181
Meireles, J., & Massano, J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00088 · Cited by 172
Differential diagnosis of Alzheimer’s disease using spectrochemical analysis of blood
Paraskevaidi, M., Morais, C. L. M., Lima, K. M. G., Snowden, J. S., Saxon, J. A., Richardson, A. M. T., Jones, M., Mann, D. M. A., Allsop, D., Martin-Hirsch, P. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701517114 · Cited by 162
Self-citationPlasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
Lopez, O. L., Kuller, L. H., Mehta, P. D., Becker, J. T., Gach, H. M., Sweet, R. A., Chang, Y. F., Tracy, R., & DeKosky, S. T. (2008) · Neurology · doi:10.1212/01.wnl.0000306696.82017.66 · Cited by 161
Cerebrospinal fluid markers for prediction of Alzheimer's disease
Zetterberg, H., Wahlund, L.-O., & Blennow, K. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.011 · Cited by 158
Ryzhikova, E., Kazakov, O., Halámková, L., Celmins, D. F., Malone, P., Molho, E., Zimmerman, E. A., & Lednev, I. K. (2014) · Journal of Biophotonics · doi:10.1002/jbio.201400060 · Cited by 155
Demeritte, T., Viraka Nellore, B. P., Kanchanapally, R., Sinha, S. S., Pramanik, A., Chavva, S. R., & Ray, P. C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b03619 · Cited by 154
Dementia in low-income and middle-income countries: Different realities mandate tailored solutions
Ferri, C. P., & Jacob, K. S. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002271 · Cited by 154 · cited 1×
“Verbal comprehension tests start to change later in the disease course: during 154 MCI they show mild or no impairment (4), and are of limited use in diagnosis.”
BackgroundHampel, H. J., Mitchell, A. J., Blennow, K., Frank, R., Brettschneider, S., Weller, L. J. R., & M�ller, H.-J. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0065-z · Cited by 147
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
Ewers, M., Buerger, K., Teipel, S. J., Scheltens, P., Schröder, J., Zinkowski, R. P., Bouwman, F. H., Schönknecht, P., Schoonenboom, N. S. M., Andreasen, N., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000286944.22262.ff · Cited by 146
Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer’s Disease
Chiu, M.-J., Yang, S.-Y., Horng, H.-E., Yang, C.-C., Chen, T.-F., Chieh, J.-J., Chen, H.-H., Chen, T.-C., Ho, C.-S., Chang, S.-F., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400129p · Cited by 139
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
Rüetschi, U., Zetterberg, H., Podust, V. N., Gottfries, J., Li, S., Simonsen, A. H., McGuire, J., Karlsson, M., Rymo, L., Davies, H., et al. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.002 · Cited by 139
Behavioral and Psychologic Symptoms in Different Types of Dementia
Chiu, M.-J., Chen, T.-F., Yip, P.-K., Hua, M.-S., & Tang, L.-Y. (2006) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60150-9 · Cited by 136
McKeith, I. G., Burn, D. J., Ballard, C. G., Collerton, D., Jaros, E., Morris, C. M., McLaren, A., Perry, E. K., Perry, R., Piggott, M. A., et al. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50006 · Cited by 135
Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
Lui, J. K., for the AIBL Research Group, Laws, S. M., Li, Q.-X., Villemagne, V. L., Ames, D., Brown, B., Bush, A. I., De Ruyck, K., Dromey, J., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-090249 · Cited by 134
APOE Genotype, Family History of Dementia, and Alzheimer Disease Risk: A 6-Year Follow-up Study
Huang, W., Qiu, C., von Strauss, E., Winblad, B., & Fratiglioni, L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1930 · Cited by 132
Blasko, I., Jellinger, K. A., Kemmler, G., Krampla, W. W., Jungwirth, S., Wichart, I., Tragl, K. H., & Fischer, P. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.002 · Cited by 130
Plaque-associated lipids in Alzheimer’s diseased brain tissue visualized by nonlinear microscopy
Kiskis, J., Fink, H., Nyberg, L., Thyr, J., Li, J.-Y., & Enejder, A. (2015) · Scientific Reports · doi:10.1038/srep13489 · Cited by 116
Nabers, A., Ollesch, J., Schartner, J., Kötting, C., Genius, J., Hafermann, H., Klafki, H., Gerwert, K., & Wiltfang, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04286 · Cited by 115
Sundelöf, J., Giedraitis, V., Irizarry, M. C., Sundström, J., Ingelsson, E., Rönnemaa, E., Ärnlöv, J., Gunnarsson, M. D., Hyman, B. T., Basun, H., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.57 · Cited by 113
Plasma levels of beta-amyloid (1–42) in Alzheimer's disease and mild cognitive impairment
Pesaresi, M., Lovati, C., Bertora, P., Mailland, E., Galimberti, D., Scarpini, E. A., Quadri, P., Forloni, G., & Mariani, C. B. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.004 · Cited by 111
Forlenza, O. V., Radanovic, M., Talib, L. L., Aprahamian, I., Diniz, B. S., Zetterberg, H., & Gattaz, W. F. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.09.003 · Cited by 109
Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies
Deramecourt, V., Bombois, S., Maurage, C.-A., Ghestem, A., Drobecq, H., Vanmechelen, E., Lebert, F., Pasquier, F., & Delacourte, A. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000205145.54457.ea · Cited by 108
Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment
Assini, A., Cammarata, S., Vitali, A., Colucci, M., Giliberto, L., Borghi, R., Inglese, M. L., Volpe, S., Ratto, S., Dagna-Bricarelli, F., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000137040.64252.ed · Cited by 104
Is apolipoprotein E4 an important risk factor for vascular dementia?
Rohn, T. T. (2014) · PubMed · Cited by 94
Dementia underdiagnosis in Brazil
Nakamura, A. E., Opaleye, D. C., Tani, G., & Ferri, C. P. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60153-2 · Cited by 94
Pradier, C., Sakarovitch, C., Duff, F. L., Layese, R., Metelkina, A., Anthony, S., Tifratène, K., & Robert, P. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103630 · Cited by 87
Leskovjan, A. C., Kretlow, A., & Miller, L. M. (2010) · Analytical Chemistry · doi:10.1021/ac1002728 · Cited by 86
Richard, E., Schmand, B. A., Eikelenboom, P., & Van Gool, W. A. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002541 · Cited by 84
Carmona, P., Molina, M., Calero, M., Bermejo‐Pareja, F., Martínez‐Martín, P., & Tolédano, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122041 · Cited by 80
Michael, R., Lenferink, A. T. M., Vrensen, G. F. J. M., Gelpí, E., Barraquer, R. I., & Otto, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-16002-3 · Cited by 68
Mordechai, S., Shufan, E., Katz, B. S. P., & Salman, A. (2016) · The Analyst · doi:10.1039/c6an01580h · Cited by 66
Sobów, T., Flirski, M., Kłoszewska, I., & Liberski, P. P. (2005) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2005-1544 · Cited by 62
Donix, M., Ercoli, L. M., Siddarth, P., Brown, J. A., Martin-Harris, L., Burggren, A. C., Miller, K. J., Small, G. W., & Bookheimer, S. Y. (2012) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3182107e6a · Cited by 62
Raman signature from brain hippocampus could aid Alzheimer's disease diagnosis
Chen, P., Shen, A., Zhao, W., Baek, S.-J., Yuan, H. M., & Hu, J. (2009) · Applied Optics · doi:10.1364/ao.48.004743 · Cited by 61
Peuchant, E., Richard‐Harston, S., Bourdel‐Marchasson, I., Dartigues, J., Letenneur, L., Barberger‐Gateau, P., Dabernat, S., & Daniel, J. Y. (2008) · Translational research · doi:10.1016/j.trsl.2008.05.009 · Cited by 49
Chen, P., Tian, Q., Baek, S., Shang, X. L., Park, A.-R., Liu, Z., Yao, X., Wang, J. Z., Wang, X., Cheng, Y., et al. (2011) · Laser Physics Letters · doi:10.1002/lapl.201110016 · Cited by 48
The influence of diagnosis, intra- and inter-person variability on serum and plasma Aβ levels
Abdullah, L. I., Paris, D., Luis, C. A., Quadros, A., Parrish, J., Valdés, L., Keegan, A. P., Mathura, V. S., Crawford, F., & MULLAN, M. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.09.058 · Cited by 44
Near-Infrared Spectroscopy of Blood Plasma for Diagnosis of Sporadic Alzheimer's Disease
Burns, D. H., Rosendahl, S. M., Bandilla, D., Maes, O. C., Chertkow, H. M., & Schipper, H. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1053 · Cited by 43
Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer’s disease
Carmona, P., Molina, M., López‐Tobar, E., & Tolédano, A. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8940-7 · Cited by 42
Screening for Early Alzheimer's Disease
Benson, A. D., Slavin, M. J., Tran, T.-T. T., Petrella, J. R., & Doraiswamy, M. P. (2005) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v07n0204 · Cited by 40
The clinical assessment of the patient with early dementia
Cooper, S. A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081133 · Cited by 40
Beach, T. G., Schneider, J. A., Sue, L. I., Serrano, G., Dugger, B. N., Monsell, S. E., & Kukull, W. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000114 · Cited by 35
Serum apolipoprotein E is associated with long-term risk of Alzheimer’s disease: The Rotterdam Study
Wolters, F. J., Koudstaal, P. J., Hofman, A., Duijn, C. M. V., & Ikram, M. A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.018 · Cited by 31
Applications of tau PET imaging
Okamura, N., & Yanai, K. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.38 · Cited by 26
Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer’s Disease
Huang, C., & Isidoro, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161238 · Cited by 25
Luo, Y., Du, Z., Yang, Y., Chen, P., Tian, Q., Shang, X. L., Liu, Z. C., Yao, X., Wang, J. Z., Wang, X. H., et al. (2013) · Laser Physics · doi:10.1088/1054-660x/23/4/045603 · Cited by 9
Magnetic Resonance Spectroscopy in the Diagnosis of Dementia with Lewy Bodies
Magierski, R., & Sobów, T. (2014) · BioMed Research International · doi:10.1155/2014/809503 · Cited by 5
Research works printed but not linked: 5
- Kroner Z., 2009, Altern. Med. Rev., 14, 373
- Casey D. A., 2010, Pharm. Ther., 35, 208
- McKeith I., 2004, Dialogues Clin. Neurosci., 6, 333, 10.31887/dcns.2004.6.3/imckeith · doi:10.31887/dcns.2004.6.3/imckeith
- Rohn T. T., 2014, Int. J. Clin. Exp. Pathol., 7, 3504
- Paraskevaidi M., 2018, under review
Cited by
Kimura, R., Tsujimura, H., Tsuchiya, M., Soga, S., Ota, N., Tanaka, A., & Kim, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-57878-y · Cited by 78
Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease
Huefner, A., Kuan, W., Mason, S., Mahajan, S., & Barker, R. A. (2019) · Chemical Science · doi:10.1039/c9sc03711j · Cited by 53
Nabers, A., Hafermann, H., Wiltfang, J., & Gerwert, K. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.01.008 · Cited by 48
Tear-Based Vibrational Spectroscopy Applied to Amyotrophic Lateral Sclerosis
Ami, D., Duse, A., Mereghetti, P., Cozza, F., Ambrosio, F., Ponzini, E., Grandori, R., Lunetta, C., Tavazzi, S., Pezzoli, F., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02546 · Cited by 44
Ami, D., Mereghetti, P., Foli, A., Tasaki, M., Milani, P., Nuvolone, M., Palladini, G. O., Merlini, G., Lavatelli, F., & Natalello, A. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05008 · Cited by 38
Metadata
- Authors
- Paraskevaidi, M., Martin-Hirsch, P. L., & Martin, F. L.
- Affiliations
- University of Lancashire (GB)
- Department of Obstetrics and Gynaecology, Central Lancashire Teaching Hospitals NHS Foundation Trust, Preston PR2 9HT, United Kingdom
- Corresponding author
- Paraskevaidi, Maria
- Martin, Francis L.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-02-01
- Volume
- 9
- Issue
- 3
- Pages
- 446-461
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2786360376
- Cited by
- 31
- References
- 153
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 1
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- Funders
- Rosemere Cancer Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia diagnosis, neurodegenerative diseases, dementia pathogenesis, risk factors, neuroimaging, cerebrospinal fluid biomarkers, blood biomarkers, infrared spectroscopy, Raman spectroscopy, disease surveillance
- MeSH terms
- Alzheimer Disease, Animals, Dementia, Humans, Risk, Spectrum Analysis, Raman, Biomarkers, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.